In OC cells, RAD1 and CHEK1 knockdown led to decreased cellular viability, increased sensitivity to cisplatin, and decreased HRR efficiency [106], while CHEK1 overexpression was associated with detrimental outcomes in early-stage ovarian cancer [98]. Here, CHEK1 is linked to ovarian carcinoma.